CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health shares climbed Tuesday after the health conglomerate raised its full-year outlook and outlined plans for a new AI ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady ...

CVS Health (CVS) stock in focus as the company raises 2025 financial guidance, but projects 2026 revenue below consensus.

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.

Fintel reports that on December 12, 2025, Bernstein maintained coverage of CVS Health (NYSE:CVS) with a Market Perform ...

CVS announced its plan to launch a new healthcare engagement platform in order to “uniquely reimagine health care through ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.